These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 15671544)

  • 1. Prognostic relevance of fragile histidine triad protein expression in patients with small cell lung cancer.
    Rohr UP; Rehfeld N; Geddert H; Pflugfelder L; Bruns I; Neukirch J; Rohrbeck A; Grote HJ; Steidl U; Fenk R; Opalka B; Gabbert HE; Kronenwett R; Haas R
    Clin Cancer Res; 2005 Jan; 11(1):180-5. PubMed ID: 15671544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coexpression of fragile histidine triad and c-kit is relevant for prediction of survival in patients with small cell lung cancer.
    Rehfeld N; Geddert H; Atamna A; Gabbert HE; Steidl U; Fenk R; Kronenwett R; Haas R; Rohr UP
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2232-8. PubMed ID: 17119051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance.
    Nakata S; Sugio K; Uramoto H; Oyama T; Hanagiri T; Morita M; Yasumoto K
    Cancer; 2006 May; 106(10):2190-9. PubMed ID: 16598757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal fragile histidine triad (FHIT) expression in advanced cervical carcinoma: a poor prognostic factor.
    Krivak TC; McBroom JW; Seidman J; Venzon D; Crothers B; MacKoul PJ; Rose GS; Carlson JW; Birrer MJ
    Cancer Res; 2001 Jun; 61(11):4382-5. PubMed ID: 11389064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of c-kit expression in small cell lung cancer: prognostic and therapeutic implications.
    Micke P; Basrai M; Faldum A; Bittinger F; Rönnstrand L; Blaukat A; Beeh KM; Oesch F; Fischer B; Buhl R; Hengstler JG
    Clin Cancer Res; 2003 Jan; 9(1):188-94. PubMed ID: 12538468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of PTEN and FHIT is involved in regulating the balance between apoptosis and proliferation in lung carcinomas.
    Zheng H; Tsuneyama K; Takahashi H; Miwa S; Nomoto K; Saito H; Masuda S; Takano Y
    Anticancer Res; 2007; 27(1B):575-81. PubMed ID: 17348444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of FHIT, CTNNB1, and MUC1 expression in non-small cell lung cancer.
    Woenckhaus M; Merk J; Stoehr R; Schaeper F; Gaumann A; Wiebe K; Hartmann A; Hofstaedter F; Dietmaier W
    Hum Pathol; 2008 Jan; 39(1):126-36. PubMed ID: 17949785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological significance of fragile histidine triad transcription protein expression in endometrial carcinomas.
    Segawa T; Sasagawa T; Saijoh K; Inoue M
    Clin Cancer Res; 2000 Jun; 6(6):2341-8. PubMed ID: 10873085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological significance of the fragile histidine triad transcription protein expression in laryngeal carcinogenesis.
    Kitamura K; Hayashi K; Kobayashi R; Ishii H; Matsubayashi J; Matsumoto T; Suzuki M
    Oncol Rep; 2008 Apr; 19(4):847-52. PubMed ID: 18357366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of FHIT expression in breast cancer is correlated with poor prognostic markers.
    Arun B; Kilic G; Yen C; Foster B; Yardley DA; Gaynor R; Ashfaq R
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1681-5. PubMed ID: 16030101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased FHIT protein expression correlates with a worse prognosis in patients with diffuse large B-cell lymphoma.
    Chen PM; Yang MH; Hsiao LT; Yu IT; Chu CJ; Chao TC; Yen CC; Wang WS; Chiou TJ; Liu JH
    Oncol Rep; 2004 Feb; 11(2):349-56. PubMed ID: 14719066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological significance of fragile histidine triad transcription protein expression in breast carcinoma.
    Yang Q; Yoshimura G; Suzuma T; Tamaki T; Umemura T; Nakamura M; Nakamura Y; Wang X; Mori I; Sakurai T; Kakudo K
    Clin Cancer Res; 2001 Dec; 7(12):3869-73. PubMed ID: 11751477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal fragile histidine triad (Fhit) expression in invasive cervical adenocarcinoma: association with tumor aggressiveness.
    Yoon SO
    Hum Pathol; 2007 Feb; 38(2):326-31. PubMed ID: 17137614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypermethylation of FHIT as a prognostic marker in nonsmall cell lung carcinoma.
    Maruyama R; Sugio K; Yoshino I; Maehara Y; Gazdar AF
    Cancer; 2004 Apr; 100(7):1472-7. PubMed ID: 15042681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation status of fragile histidine triad (FHIT) gene and its clinical impact on prognosis of patients with multiple myeloma.
    Takada S; Morita K; Hayashi K; Matsushima T; Sawamura M; Murakami H; Nojima Y
    Eur J Haematol; 2005 Dec; 75(6):505-10. PubMed ID: 16313263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The fragile genes FHIT and WWOX are inactivated coordinately in invasive breast carcinoma.
    Guler G; Uner A; Guler N; Han SY; Iliopoulos D; Hauck WW; McCue P; Huebner K
    Cancer; 2004 Apr; 100(8):1605-14. PubMed ID: 15073846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of fragile histidine triad expression in tumors from saudi arabia: a tissue microarray analysis.
    Bavi P; Jehan Z; Atizado V; Al-Dossari H; Al-Dayel F; Tulbah A; Amr SS; Sheikh SS; Ezzat A; El-Solh H; Uddin S; Al-Kuraya K
    Cancer Epidemiol Biomarkers Prev; 2006 Sep; 15(9):1708-18. PubMed ID: 16985034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inverse correlation of aberrant expression of fragile histidine triad (FHIT) protein with cyclin D1 protein and prognosis in Chinese patients with cholangiocarcinoma.
    Zhao P; Lu Y; Zhong M; Liu L; Li B
    Acta Oncol; 2008; 47(8):1557-63. PubMed ID: 18618300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of nuclear factor-kappa-B/P65 and fragile histidine triad in colorectal carcinoma and clinical significance thereof].
    Lü Y; Liu L; Zhao P
    Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(9):610-4. PubMed ID: 18646716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FHIT expression in clear cell renal carcinomas: versatility of protein levels and correlation with survival.
    Ramp U; Caliskan E; Ebert T; Karagiannidis C; Willers R; Gabbert HE; Gerharz CD
    J Pathol; 2002 Apr; 196(4):430-6. PubMed ID: 11920739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.